Evidence map›Paper›PMID 31566076›Full record

Observational studyTherapeutic advances in respiratory disease

Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities.

John Papanikolaou, Melpomeni Ntalapascha, Demosthenes Makris, Triantafyllia Koukoubani, Vasiliki Tsolaki, George Zakynthinos, Konstantinos Gourgoulianis, Epaminondas Zakynthinos

Abstract readObservational Study
In one paragraph

Observational study in Therapeutic advances in respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

John PapanikolaouDepartment of Critical Care, University Hospital of Larissa, Biopolis, Larissa, 41110, Greece.ORCID 0000-0002-1341-6668
Melpomeni NtalapaschaDepartment of Cardiology, University Hospital of Larissa, Larissa, Thessaly, Greece.
Demosthenes MakrisDepartment of Critical Care, University Hospital of Larissa, Larissa, Thessaly, Greece.
Triantafyllia KoukoubaniDepartment of Critical Care, University Hospital of Larissa, Larissa, Thessaly, Greece.
Vasiliki TsolakiDepartment of Critical Care, University Hospital of Larissa, Larissa, Thessaly, Greece.
George ZakynthinosDepartment of Critical Care, University Hospital of Larissa, Larissa, Thessaly, Greece.
Konstantinos GourgoulianisDepartment of Pulmonology, University Hospital of Larissa, Larissa, Thessaly, Greece.
Epaminondas ZakynthinosDepartment of Critical Care, University Hospital of Larissa, Larissa, Thessaly, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to evaluate whether the severity of obstructive sleep apnea syndrome (OSAS)

methodsA total of 42 patients with first-diagnosed severe OSAS [apnea-hypopnea index (AHI) > 30] and 25 controls (AHI < 5), having been referred for snoring to the Sleep Laboratory Department of our tertiary Hospital, were enrolled in the study. Inclusion criteria were absence of any cardiovascular or oxidative stress-related comorbidities, and age between 20 and 70 years. Clinical, laboratory, echocardiographic, and polysomnographic data were recorded prospectively. Diastolic dysfunction diagnosis and grading was based on 2016 ASE/EACVI recommendations.

resultsSevere OSAS was associated with significantly increased prevalence and degree of diastolic dysfunction (26/42; 61.9%) compared with controls (7/25; 28%) (

conclusionsThe present prospective study may suggest that severe OSAS is significantly associated with LV diastolic dysfunction; OSAS clinical severity exerts a positive influence on (and possibly constitutes an independent risk factor of) LV diastolic dysfunction.

Indexed as

Ventricular Function, LeftAdultAgedBiomarkersCase-Control StudiesComorbidityC-Reactive ProteinDiastoleGreeceHumansInflammation MediatorsMaleMiddle AgedNatriuretic Peptide, BrainPrevalenceProspective StudiesBiomarkersC-Reactive ProteinInflammation MediatorsNatriuretic Peptide, BrainVascular Endothelial Growth Factor BVEGFB protein, humancomorbiditydiastolic dysfunctionGSHGSSGobstructive sleep apnea syndromeoxidative stress

Identifiers

PMID31566076
PMCPMC6769220

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.